{
  "id": "46_ref_0",
  "query": "已知：目标分子为吡格列酮（Pioglitazone），SMILES：CCc1ccc(cc1)CCOc2ccc(cc2)CC(=O)NC3=CC(=O)S(=O)(=O)C3。给定数据如下（按所示单位）：\n- 规范化SMILES（canonical）：CCc1ccc(cc1)CCOc2ccc(cc2)CC(=O)NC3=CC(=O)S(=O)(=O)C3\n- 合成可及性分数（SAS）：原始SMILES：3.7；规范化SMILES：3.7\n- 力场优化能量：MMFF：112.5 kcal/mol；UFF：111.2 kcal/mol\n- 3D形状描述符：\n  • MMFF：回转半径 Rg：2.78 Å；主惯性矩 PMI（I1≤I2≤I3）：[530, 1080, 1560] amu·Å^2；惯性形状因子：0.66（无量纲）；球形度：0.52（无量纲）；离心率：0.77（无量纲）；非球形度：0.35（无量纲）\n  • UFF：回转半径 Rg：2.82 Å；主惯性矩 PMI（I1≤I2≤I3）：[545, 1105, 1585] amu·Å^2；惯性形状因子：0.65（无量纲）；球形度：0.51（无量纲）；离心率：0.78（无量纲）；非球形度：0.36（无量纲）\n- 成药性相关理化性质：logP：2.3；氢键供体 HBD：1；氢键受体 HBA：5；拓扑极性表面积 TPSA：68.3 Å^2；可旋转键数：7\n- 图像/文件路径：2D图像：./artifacts/pioglitazone_2d.png；3D模型（MMFF）：./artifacts/pioglitazone_3d_MMFF.mol2；3D模型（UFF）：./artifacts/pioglitazone_3d_UFF.mol2\n任务：\n(1) 报告最终SAS分数（保留1位小数），并说明原始与规范化SMILES的SAS是否一致。\n(2) 给出MMFF与UFF优化能量及其能量差ΔE（kcal/mol，保留1位小数），并验证是否满足ΔE≤2 kcal/mol。\n(3) 分别给出两套3D形状描述符（至少含Rg、PMI三分量、惯性形状因子、球形度、离心率、非球形度），并以MMFF为基准计算上述各项相对差异（% ，保留2位小数），验证是否均<10%。\n(4) 报告Lipinski五规则评估结果（是否通过、违规数目），并给出logP、HBD、HBA、TPSA、可旋转键数。\n(5) 提供规范化SMILES与2D/3D文件路径。\n(6) 汇总一致性检验结论；如有不满足阈值的项，需标注与解释。\n结果以数值形式给出：SAS保留1位小数；ΔE保留1位小数（kcal/mol）；相对差异保留2位小数（%）；其余量按所示单位原样报告。",
  "query_data": {
    "id": "46_ref_0",
    "original_id": 46,
    "refined_index": 0,
    "question": "已知：目标分子为吡格列酮（Pioglitazone），SMILES：CCc1ccc(cc1)CCOc2ccc(cc2)CC(=O)NC3=CC(=O)S(=O)(=O)C3。给定数据如下（按所示单位）：\n- 规范化SMILES（canonical）：CCc1ccc(cc1)CCOc2ccc(cc2)CC(=O)NC3=CC(=O)S(=O)(=O)C3\n- 合成可及性分数（SAS）：原始SMILES：3.7；规范化SMILES：3.7\n- 力场优化能量：MMFF：112.5 kcal/mol；UFF：111.2 kcal/mol\n- 3D形状描述符：\n  • MMFF：回转半径 Rg：2.78 Å；主惯性矩 PMI（I1≤I2≤I3）：[530, 1080, 1560] amu·Å^2；惯性形状因子：0.66（无量纲）；球形度：0.52（无量纲）；离心率：0.77（无量纲）；非球形度：0.35（无量纲）\n  • UFF：回转半径 Rg：2.82 Å；主惯性矩 PMI（I1≤I2≤I3）：[545, 1105, 1585] amu·Å^2；惯性形状因子：0.65（无量纲）；球形度：0.51（无量纲）；离心率：0.78（无量纲）；非球形度：0.36（无量纲）\n- 成药性相关理化性质：logP：2.3；氢键供体 HBD：1；氢键受体 HBA：5；拓扑极性表面积 TPSA：68.3 Å^2；可旋转键数：7\n- 图像/文件路径：2D图像：./artifacts/pioglitazone_2d.png；3D模型（MMFF）：./artifacts/pioglitazone_3d_MMFF.mol2；3D模型（UFF）：./artifacts/pioglitazone_3d_UFF.mol2\n任务：\n(1) 报告最终SAS分数（保留1位小数），并说明原始与规范化SMILES的SAS是否一致。\n(2) 给出MMFF与UFF优化能量及其能量差ΔE（kcal/mol，保留1位小数），并验证是否满足ΔE≤2 kcal/mol。\n(3) 分别给出两套3D形状描述符（至少含Rg、PMI三分量、惯性形状因子、球形度、离心率、非球形度），并以MMFF为基准计算上述各项相对差异（% ，保留2位小数），验证是否均<10%。\n(4) 报告Lipinski五规则评估结果（是否通过、违规数目），并给出logP、HBD、HBA、TPSA、可旋转键数。\n(5) 提供规范化SMILES与2D/3D文件路径。\n(6) 汇总一致性检验结论；如有不满足阈值的项，需标注与解释。\n结果以数值形式给出：SAS保留1位小数；ΔE保留1位小数（kcal/mol）；相对差异保留2位小数（%）；其余量按所示单位原样报告。",
    "answer": "{'(1) 最终SAS与一致性': {'SAS_final': '3.7（无量纲）', 'SAS_original_SMILES': '3.7（无量纲）', 'SAS_normalized_SMILES': '3.7（无量纲）', 'cross_validated_consistent': True}, '(2) 能量与差异': {'E_MMFF': '112.5 kcal/mol', 'E_UFF': '111.2 kcal/mol', 'ΔE': '1.3 kcal/mol', 'verify_ΔE_le_2_kcal_per_mol': True}, '(3) 3D形状描述符与相对差异': {'MMFF': {'Rg': '2.78 Å', 'PMI': ['530 amu·Å^2', '1080 amu·Å^2', '1560 amu·Å^2'], 'inertial_shape_factor': '0.66（无量纲）', 'sphericity': '0.52（无量纲）', 'eccentricity': '0.77（无量纲）', 'asphericity': '0.35（无量纲）'}, 'UFF': {'Rg': '2.82 Å', 'PMI': ['545 amu·Å^2', '1105 amu·Å^2', '1585 amu·Å^2'], 'inertial_shape_factor': '0.65（无量纲）', 'sphericity': '0.51（无量纲）', 'eccentricity': '0.78（无量纲）', 'asphericity': '0.36（无量纲）'}, 'relative_differences_%_vs_MMFF': {'Rg': '1.44%', 'PMI_I1': '2.83%', 'PMI_I2': '2.31%', 'PMI_I3': '1.60%', 'inertial_shape_factor': '1.52%', 'sphericity': '1.92%', 'eccentricity': '1.30%', 'asphericity': '2.86%', 'all_metrics_below_10%': True}}, '(4) 成药性评估': {'passes_rule_of_five': True, 'violations': 0, 'logP': '2.3（无量纲）', 'HBD': '1（个）', 'HBA': '5（个）', 'TPSA': '68.3 Å^2', 'rotatable_bonds': '7（个）'}, '(5) 结构与文件路径': {'normalized_SMILES': 'CCc1ccc(cc1)CCOc2ccc(cc2)CC(=O)NC3=CC(=O)S(=O)(=O)C3', 'image_2D_path': './artifacts/pioglitazone_2d.png', 'model_3D_MMFF_path': './artifacts/pioglitazone_3d_MMFF.mol2', 'model_3D_UFF_path': './artifacts/pioglitazone_3d_UFF.mol2'}, '(6) 一致性汇总': {'SAS_original_vs_normalized_agree': True, 'energy_difference_le_2_kcal_per_mol': True, 'shape_metrics_relative_diff_lt_10_percent': True, 'lipinski_pass': True, 'notes': '所有阈值均满足，无需额外说明。'}}",
    "metadata": {
      "subject": "化学",
      "topic": "药物化学与合成可及性",
      "image_path": [],
      "solution_steps": [
        "【分子识别与解析】解析Pioglitazone的SMILES字符串：CCc1ccc(cc1)CCOc2ccc(cc2)CC(=O)NC3=CC(=O)S(=O)(=O)C3",
        "识别结构特征：噻唑烷二酮核心结构 + 双苯基侧链 + 柔性醚键连接",
        "【SAS计算】调用 calculate_synthetic_accessibility(smiles) 使用Ertl-Schuffenhauer算法",
        "基于分子复杂度、环系统（3个环：2个苯环+1个噻唑烷二酮环）、立体化学和合成片段库进行评估",
        "获得SAS = 2.7，处于\"相对容易合成\"范围（2.0-4.0）",
        "该分数反映了噻唑烷二酮类药物的典型合成可及性，适合商业化开发",
        "【理化性质分析】调用 mol_basic_physicochemical_info(smiles) 获取完整分子信息",
        "分子式：C22H23NO5S，分子量：413.13 g/mol（中等分子量药物）",
        "LogP = 2.37（良好的脂水平衡，有利于口服吸收）",
        "TPSA = 89.54 Ų（<140 Ų，有利于穿透生物膜）",
        "氢键供体：1（酰胺NH），氢键受体：5（羰基O + 磺酰O + 醚O）",
        "可旋转键：8（柔性侧链，有利于与受体结合）",
        "芳香环：2（双苯基结构），总环数：3（含噻唑烷二酮环）",
        "【Lipinski成药性评估】检查Lipinski五规则的四个标准",
        "✓ MW(413.13) ≤ 500 - 符合",
        "✓ LogP(2.37) ≤ 5 - 符合",
        "✓ HBD(1) ≤ 5 - 符合",
        "✓ HBA(5) ≤ 10 - 符合",
        "违规数 = 0，类药性 = ✓ 是（完全符合成药标准）",
        "【3D可视化】调用 chem_visualizer 生成多种视图",
        "生成Pioglitazone_2d.png：2D平面结构图，展示双苯基-醚-噻唑烷二酮骨架",
        "生成Pioglitazone_3d_projection.png：3D投影图，展示空间构象",
        "生成Pioglitazone_3d_matplotlib.png：3D立体图，展示柔性侧链的伸展构象",
        "【3D结构优化】调用 optimize_geometry(smiles, method='ETKDGv3', force_field='MMFF', max_iters=200)",
        "使用ETKDGv3算法生成初始3D坐标（改进的距离几何方法）",
        "初始能量：209.15 kcal/mol（未优化状态）",
        "MMFF力场优化后：146.69 kcal/mol",
        "能量降低：ΔE = -62.46 kcal/mol（显著的结构弛豫）",
        "优化消除了构象张力，得到能量最低的稳定构象",
        "【3D性质计算】调用 get_3d_properties(smiles, method='ETKDGv3', conf_id=0)",
        "主惯性矩：PMI1=1571.08, PMI2=13235.79, PMI3=13960.64 amu·Ų",
        "归一化惯性矩比：NPR1=0.113（PMI1/PMI3），NPR2=0.948（PMI2/PMI3）",
        "分子形状分类：极端棒状/纤维状（NPR1 < 0.5 且 NPR2 > 0.95）",
        "这种拉伸构象有利于插入PPARγ受体的结合口袋",
        "回转半径：Rg = 5.898 Å（分子质量分布的特征尺度）",
        "非球形度：asphericity = 0.701（高度偏离球形，0=球形，1=完全非球形）",
        "偏心率：eccentricity = 0.994（接近1，表示极度拉伸的椭球形）",
        "【结构-活性关系分析】双苯基侧链提供疏水相互作用",
        "噻唑烷二酮环是PPARγ激动的关键药效团",
        "柔性醚键允许构象适应性结合",
        "【合成难度评估】SAS=2.7对应\"相对容易合成\"（★★☆☆☆）",
        "合成路线：商品化起始原料 + 常规有机反应（醚化、酰化、环化）",
        "无复杂手性中心，合成步骤可控，适合大规模生产",
        "【药物开发价值】成药性优异（Lipinski零违规）+ 合成可及（SAS低）",
        "相比第一代曲格列酮（肝毒性）和第二代罗格列酮（心血管风险），吡格列酮安全性更好",
        "【最终答案】合成可及性分数 SAS = 2.7"
      ],
      "tool_expected": [
        "calculate_synthetic_accessibility",
        "mol_basic_physicochemical_info",
        "chem_visualizer",
        "optimize_geometry",
        "get_3d_properties"
      ],
      "golden_answer": [
        {
          "(1) 最终SAS与一致性": {
            "SAS_final": "3.7（无量纲）",
            "SAS_original_SMILES": "3.7（无量纲）",
            "SAS_normalized_SMILES": "3.7（无量纲）",
            "cross_validated_consistent": true
          },
          "(2) 能量与差异": {
            "E_MMFF": "112.5 kcal/mol",
            "E_UFF": "111.2 kcal/mol",
            "ΔE": "1.3 kcal/mol",
            "verify_ΔE_le_2_kcal_per_mol": true
          },
          "(3) 3D形状描述符与相对差异": {
            "MMFF": {
              "Rg": "2.78 Å",
              "PMI": [
                "530 amu·Å^2",
                "1080 amu·Å^2",
                "1560 amu·Å^2"
              ],
              "inertial_shape_factor": "0.66（无量纲）",
              "sphericity": "0.52（无量纲）",
              "eccentricity": "0.77（无量纲）",
              "asphericity": "0.35（无量纲）"
            },
            "UFF": {
              "Rg": "2.82 Å",
              "PMI": [
                "545 amu·Å^2",
                "1105 amu·Å^2",
                "1585 amu·Å^2"
              ],
              "inertial_shape_factor": "0.65（无量纲）",
              "sphericity": "0.51（无量纲）",
              "eccentricity": "0.78（无量纲）",
              "asphericity": "0.36（无量纲）"
            },
            "relative_differences_%_vs_MMFF": {
              "Rg": "1.44%",
              "PMI_I1": "2.83%",
              "PMI_I2": "2.31%",
              "PMI_I3": "1.60%",
              "inertial_shape_factor": "1.52%",
              "sphericity": "1.92%",
              "eccentricity": "1.30%",
              "asphericity": "2.86%",
              "all_metrics_below_10%": true
            }
          },
          "(4) 成药性评估": {
            "passes_rule_of_five": true,
            "violations": 0,
            "logP": "2.3（无量纲）",
            "HBD": "1（个）",
            "HBA": "5（个）",
            "TPSA": "68.3 Å^2",
            "rotatable_bonds": "7（个）"
          },
          "(5) 结构与文件路径": {
            "normalized_SMILES": "CCc1ccc(cc1)CCOc2ccc(cc2)CC(=O)NC3=CC(=O)S(=O)(=O)C3",
            "image_2D_path": "./artifacts/pioglitazone_2d.png",
            "model_3D_MMFF_path": "./artifacts/pioglitazone_3d_MMFF.mol2",
            "model_3D_UFF_path": "./artifacts/pioglitazone_3d_UFF.mol2"
          },
          "(6) 一致性汇总": {
            "SAS_original_vs_normalized_agree": true,
            "energy_difference_le_2_kcal_per_mol": true,
            "shape_metrics_relative_diff_lt_10_percent": true,
            "lipinski_pass": true,
            "notes": "所有阈值均满足，无需额外说明。"
          }
        }
      ],
      "original_question_id": "46",
      "test_type": "refined"
    },
    "usage_tool_protocol": [
      {
        "type": "function",
        "function": {
          "name": "calculate_synthetic_accessibility",
          "description": "计算分子的合成可及性分数（Synthetic Accessibility Score, SAS）。基于Ertl-Schuffenhauer算法，评估有机分子的合成难度。",
          "strict": true,
          "parameters": {
            "type": "object",
            "properties": {
              "smiles": {
                "type": "string",
                "description": "分子的SMILES表示字符串，或化学名称（会自动转换）。例如: 'CCO'（乙醇）, 'CC(=O)Oc1ccccc1C(=O)O'（阿司匹林）, 'aspirin'"
              }
            },
            "required": [
              "smiles"
            ],
            "additionalProperties": false
          }
        },
        "additionalProperties": {
          "function_path": "./tools/chemistry_tools/molecule_analyzer.py",
          "return_type": "float",
          "return_range": "1.0-10.0",
          "return_interpretation": "1.0=非常容易合成, 2.0-4.0=相对容易, 4.0-6.0=中等难度, 6.0-8.0=较难, 8.0-10.0=非常难",
          "algorithm": "Ertl & Schuffenhauer (2009) - 基于分子复杂度和片段贡献",
          "reference": "Journal of Cheminformatics, 1(1), 8"
        }
      },
      {
        "type": "function",
        "function": {
          "name": "mol_basic_physicochemical_info",
          "description": "计算分子的基本理化性质和类药性评估。提供分子的基本信息、物化性质和Lipinski五规则评估。",
          "strict": true,
          "parameters": {
            "type": "object",
            "properties": {
              "smiles": {
                "type": "string",
                "description": "分子的SMILES表示字符串，或化学名称（会自动转换）。例如: 'CCO', 'CC(=O)Oc1ccccc1C(=O)O', 'aspirin'"
              }
            },
            "required": [
              "smiles"
            ],
            "additionalProperties": false
          }
        },
        "additionalProperties": {
          "function_path": "./tools/chemistry_tools/molecule_analyzer.py"
        }
      },
      {
        "type": "function",
        "function": {
          "name": "chem_visualizer",
          "description": "分子可视化工具，支持批量生成分子的2D结构图和3D结构图。直接生成图片文件到当前目录。",
          "strict": true,
          "parameters": {
            "type": "object",
            "properties": {
              "molecules": {
                "type": "object",
                "description": "分子字典，键为分子名称，值为SMILES字符串。例如: {'ethanol': 'CCO', 'benzene': 'c1ccccc1'}"
              }
            },
            "required": [
              "molecules"
            ],
            "additionalProperties": false
          }
        },
        "additionalProperties": {
          "function_path": "./tools/chemistry_tools/molecule_visualize.py"
        }
      },
      {
        "type": "function",
        "function": {
          "name": "optimize_geometry",
          "description": "对分子进行3D几何优化，使用力场方法最小化能量。",
          "strict": true,
          "parameters": {
            "type": "object",
            "properties": {
              "smiles": {
                "type": "string",
                "description": "分子的SMILES表示字符串"
              },
              "method": {
                "type": "string",
                "description": "3D坐标生成方法",
                "enum": [
                  "ETKDGv3",
                  "ETKDG",
                  "KDG",
                  "distance_geometry"
                ]
              },
              "force_field": {
                "type": "string",
                "description": "力场类型，MMFF（Merck分子力场）或UFF（通用力场）",
                "enum": [
                  "MMFF",
                  "UFF"
                ]
              },
              "max_iters": {
                "type": "integer",
                "description": "最大优化迭代次数，默认200"
              }
            },
            "required": [
              "smiles",
              "method"
            ],
            "additionalProperties": false
          }
        },
        "additionalProperties": {
          "function_path": "./tools/chemistry_tools/molecule_analyzer.py"
        }
      },
      {
        "type": "function",
        "function": {
          "name": "get_3d_properties",
          "description": "计算分子的3D性质，包括主惯性矩、形状描述符、回转半径等。",
          "strict": true,
          "parameters": {
            "type": "object",
            "properties": {
              "smiles": {
                "type": "string",
                "description": "分子的SMILES表示字符串"
              },
              "method": {
                "type": "string",
                "description": "3D坐标生成方法",
                "enum": [
                  "ETKDGv3",
                  "ETKDG",
                  "KDG"
                ]
              },
              "conf_id": {
                "type": "integer",
                "description": "构象ID，默认为0（第一个构象）"
              }
            },
            "required": [
              "smiles",
              "method"
            ],
            "additionalProperties": false
          }
        },
        "additionalProperties": {
          "function_path": "./tools/chemistry_tools/molecule_analyzer.py"
        }
      }
    ],
    "refined_version_data": {
      "refined_question": "已知：目标分子为吡格列酮（Pioglitazone），SMILES：CCc1ccc(cc1)CCOc2ccc(cc2)CC(=O)NC3=CC(=O)S(=O)(=O)C3。给定数据如下（按所示单位）：\n- 规范化SMILES（canonical）：CCc1ccc(cc1)CCOc2ccc(cc2)CC(=O)NC3=CC(=O)S(=O)(=O)C3\n- 合成可及性分数（SAS）：原始SMILES：3.7；规范化SMILES：3.7\n- 力场优化能量：MMFF：112.5 kcal/mol；UFF：111.2 kcal/mol\n- 3D形状描述符：\n  • MMFF：回转半径 Rg：2.78 Å；主惯性矩 PMI（I1≤I2≤I3）：[530, 1080, 1560] amu·Å^2；惯性形状因子：0.66（无量纲）；球形度：0.52（无量纲）；离心率：0.77（无量纲）；非球形度：0.35（无量纲）\n  • UFF：回转半径 Rg：2.82 Å；主惯性矩 PMI（I1≤I2≤I3）：[545, 1105, 1585] amu·Å^2；惯性形状因子：0.65（无量纲）；球形度：0.51（无量纲）；离心率：0.78（无量纲）；非球形度：0.36（无量纲）\n- 成药性相关理化性质：logP：2.3；氢键供体 HBD：1；氢键受体 HBA：5；拓扑极性表面积 TPSA：68.3 Å^2；可旋转键数：7\n- 图像/文件路径：2D图像：./artifacts/pioglitazone_2d.png；3D模型（MMFF）：./artifacts/pioglitazone_3d_MMFF.mol2；3D模型（UFF）：./artifacts/pioglitazone_3d_UFF.mol2\n任务：\n(1) 报告最终SAS分数（保留1位小数），并说明原始与规范化SMILES的SAS是否一致。\n(2) 给出MMFF与UFF优化能量及其能量差ΔE（kcal/mol，保留1位小数），并验证是否满足ΔE≤2 kcal/mol。\n(3) 分别给出两套3D形状描述符（至少含Rg、PMI三分量、惯性形状因子、球形度、离心率、非球形度），并以MMFF为基准计算上述各项相对差异（% ，保留2位小数），验证是否均<10%。\n(4) 报告Lipinski五规则评估结果（是否通过、违规数目），并给出logP、HBD、HBA、TPSA、可旋转键数。\n(5) 提供规范化SMILES与2D/3D文件路径。\n(6) 汇总一致性检验结论；如有不满足阈值的项，需标注与解释。\n结果以数值形式给出：SAS保留1位小数；ΔE保留1位小数（kcal/mol）；相对差异保留2位小数（%）；其余量按所示单位原样报告。",
      "final_answer": {
        "(1) 最终SAS与一致性": {
          "SAS_final": "3.7（无量纲）",
          "SAS_original_SMILES": "3.7（无量纲）",
          "SAS_normalized_SMILES": "3.7（无量纲）",
          "cross_validated_consistent": true
        },
        "(2) 能量与差异": {
          "E_MMFF": "112.5 kcal/mol",
          "E_UFF": "111.2 kcal/mol",
          "ΔE": "1.3 kcal/mol",
          "verify_ΔE_le_2_kcal_per_mol": true
        },
        "(3) 3D形状描述符与相对差异": {
          "MMFF": {
            "Rg": "2.78 Å",
            "PMI": [
              "530 amu·Å^2",
              "1080 amu·Å^2",
              "1560 amu·Å^2"
            ],
            "inertial_shape_factor": "0.66（无量纲）",
            "sphericity": "0.52（无量纲）",
            "eccentricity": "0.77（无量纲）",
            "asphericity": "0.35（无量纲）"
          },
          "UFF": {
            "Rg": "2.82 Å",
            "PMI": [
              "545 amu·Å^2",
              "1105 amu·Å^2",
              "1585 amu·Å^2"
            ],
            "inertial_shape_factor": "0.65（无量纲）",
            "sphericity": "0.51（无量纲）",
            "eccentricity": "0.78（无量纲）",
            "asphericity": "0.36（无量纲）"
          },
          "relative_differences_%_vs_MMFF": {
            "Rg": "1.44%",
            "PMI_I1": "2.83%",
            "PMI_I2": "2.31%",
            "PMI_I3": "1.60%",
            "inertial_shape_factor": "1.52%",
            "sphericity": "1.92%",
            "eccentricity": "1.30%",
            "asphericity": "2.86%",
            "all_metrics_below_10%": true
          }
        },
        "(4) 成药性评估": {
          "passes_rule_of_five": true,
          "violations": 0,
          "logP": "2.3（无量纲）",
          "HBD": "1（个）",
          "HBA": "5（个）",
          "TPSA": "68.3 Å^2",
          "rotatable_bonds": "7（个）"
        },
        "(5) 结构与文件路径": {
          "normalized_SMILES": "CCc1ccc(cc1)CCOc2ccc(cc2)CC(=O)NC3=CC(=O)S(=O)(=O)C3",
          "image_2D_path": "./artifacts/pioglitazone_2d.png",
          "model_3D_MMFF_path": "./artifacts/pioglitazone_3d_MMFF.mol2",
          "model_3D_UFF_path": "./artifacts/pioglitazone_3d_UFF.mol2"
        },
        "(6) 一致性汇总": {
          "SAS_original_vs_normalized_agree": true,
          "energy_difference_le_2_kcal_per_mol": true,
          "shape_metrics_relative_diff_lt_10_percent": true,
          "lipinski_pass": true,
          "notes": "所有阈值均满足，无需额外说明。"
        }
      }
    },
    "metadata_summary": {
      "subject": "化学",
      "topic": "药物化学与合成可及性",
      "test_type": "refined",
      "original_question_id": "46",
      "subject_topic_key": "化学::药物化学与合成可及性"
    }
  },
  "model": "gemini-2.5-pro",
  "use_tools": true,
  "mode": "tool_mode",
  "rounds": 1,
  "messages": [
    {
      "role": "user",
      "content": "已知：目标分子为吡格列酮（Pioglitazone），SMILES：CCc1ccc(cc1)CCOc2ccc(cc2)CC(=O)NC3=CC(=O)S(=O)(=O)C3。给定数据如下（按所示单位）：\n- 规范化SMILES（canonical）：CCc1ccc(cc1)CCOc2ccc(cc2)CC(=O)NC3=CC(=O)S(=O)(=O)C3\n- 合成可及性分数（SAS）：原始SMILES：3.7；规范化SMILES：3.7\n- 力场优化能量：MMFF：112.5 kcal/mol；UFF：111.2 kcal/mol\n- 3D形状描述符：\n  • MMFF：回转半径 Rg：2.78 Å；主惯性矩 PMI（I1≤I2≤I3）：[530, 1080, 1560] amu·Å^2；惯性形状因子：0.66（无量纲）；球形度：0.52（无量纲）；离心率：0.77（无量纲）；非球形度：0.35（无量纲）\n  • UFF：回转半径 Rg：2.82 Å；主惯性矩 PMI（I1≤I2≤I3）：[545, 1105, 1585] amu·Å^2；惯性形状因子：0.65（无量纲）；球形度：0.51（无量纲）；离心率：0.78（无量纲）；非球形度：0.36（无量纲）\n- 成药性相关理化性质：logP：2.3；氢键供体 HBD：1；氢键受体 HBA：5；拓扑极性表面积 TPSA：68.3 Å^2；可旋转键数：7\n- 图像/文件路径：2D图像：./artifacts/pioglitazone_2d.png；3D模型（MMFF）：./artifacts/pioglitazone_3d_MMFF.mol2；3D模型（UFF）：./artifacts/pioglitazone_3d_UFF.mol2\n任务：\n(1) 报告最终SAS分数（保留1位小数），并说明原始与规范化SMILES的SAS是否一致。\n(2) 给出MMFF与UFF优化能量及其能量差ΔE（kcal/mol，保留1位小数），并验证是否满足ΔE≤2 kcal/mol。\n(3) 分别给出两套3D形状描述符（至少含Rg、PMI三分量、惯性形状因子、球形度、离心率、非球形度），并以MMFF为基准计算上述各项相对差异（% ，保留2位小数），验证是否均<10%。\n(4) 报告Lipinski五规则评估结果（是否通过、违规数目），并给出logP、HBD、HBA、TPSA、可旋转键数。\n(5) 提供规范化SMILES与2D/3D文件路径。\n(6) 汇总一致性检验结论；如有不满足阈值的项，需标注与解释。\n结果以数值形式给出：SAS保留1位小数；ΔE保留1位小数（kcal/mol）；相对差异保留2位小数（%）；其余量按所示单位原样报告。"
    },
    {
      "role": "assistant",
      "content": "好的，这是对吡格列酮（Pioglitazone）分子数据的分析报告：\n\n### 吡格列酮（Pioglitazone）分子性质分析报告\n\n#### 1. 合成可及性分数 (SAS)\n- **最终SAS分数**：**3.7**\n- **一致性**：原始SMILES与规范化SMILES的SAS分数一致，均为3.7。\n\n#### 2. 力场优化与能量分析\n- **MMFF优化能量**：112.5 kcal/mol\n- **UFF优化能量**：111.2 kcal/mol\n- **能量差 (ΔE)**：ΔE = |112.5 - 111.2| = **1.3 kcal/mol**\n- **验证**：能量差ΔE (1.3 kcal/mol) **满足 ≤ 2 kcal/mol** 的阈值标准。\n\n#### 3. 3D形状描述符比较\n下表展示了基于MMFF和UFF力场优化的3D形状描述符及其相对差异。\n\n| 描述符 | MMFF | UFF | 相对差异 (%) |\n| :--- | :--- | :--- | :--- |\n| 回转半径 Rg (Å) | 2.78 | 2.82 | 1.44% |\n| 主惯性矩 PMI-I1 (amu·Å²) | 530 | 545 | 2.83% |\n| 主惯性矩 PMI-I2 (amu·Å²) | 1080 | 1105 | 2.31% |\n| 主惯性矩 PMI-I3 (amu·Å²) | 1560 | 1585 | 1.60% |\n| 惯性形状因子 | 0.66 | 0.65 | -1.52% |\n| 球形度 | 0.52 | 0.51 | -1.92% |\n| 离心率 | 0.77 | 0.78 | 1.30% |\n| 非球形度 | 0.35 | 0.36 | 2.86% |\n\n- **验证**：所有描述符的相对差异（绝对值）**均 < 10%**，满足一致性要求。\n\n#### 4. Lipinski五规则与类药性\n- **Lipinski五规则评估**：**通过 (Pass)**，**0个违规**。\n- **成药性相关理化性质**：\n    - **logP**: 2.3\n    - **氢键供体 (HBD)**: 1\n    - **氢键受体 (HBA)**: 5\n    - **拓扑极性表面积 (TPSA)**: 68.3 Å²\n    - **可旋转键数**: 7\n\n#### 5. 分子标识与文件路径\n- **规范化SMILES**: `CCc1ccc(cc1)CCOc2ccc(cc2)CC(=O)NC3=CC(=O)S(=O)(=O)C3`\n- **2D结构图像**: `./artifacts/pioglitazone_2d.png`\n- **3D模型 (MMFF)**: `./artifacts/pioglitazone_3d_MMFF.mol2`\n- **3D模型 (UFF)**: `./artifacts/pioglitazone_3d_UFF.mol2`\n\n#### 6. 综合一致性结论\n所有检验项均满足预设的阈值标准：\n1.  **SAS一致性**：原始与规范化SMILES的SAS分数一致。\n2.  **能量一致性**：MMFF与UFF优化能量差ΔE (1.3 kcal/mol) 在允许范围内 (≤ 2 kcal/mol)。\n3.  **构象一致性**：两种力场产生的3D构象在关键形状描述符上的相对差异均小于10%。\n\n结论：**两种计算方法（MMFF和UFF）在预测吡格列酮分子的能量和三维形状方面表现出良好的一致性。**"
    },
    {
      "role": "user",
      "content": "现在请仅输出严格 JSON，必须完全匹配以下结构（键名、层级、字段齐全），所有数值用数字表示（保留2-3位小数），布尔用 true/false，字符串填写说明文字。不要输出任何解释文字或前后缀，也不要多余字段；若无法计算某值请给出可解析的近似值。\n\n{\n  \"(1) 最终SAS与一致性\": {\n    \"SAS_final\": \"[字符串]\",\n    \"SAS_original_SMILES\": \"[字符串]\",\n    \"SAS_normalized_SMILES\": \"[字符串]\",\n    \"cross_validated_consistent\": \"[布尔值]\"\n  },\n  \"(2) 能量与差异\": {\n    \"E_MMFF\": \"[字符串]\",\n    \"E_UFF\": \"[字符串]\",\n    \"ΔE\": \"[字符串]\",\n    \"verify_ΔE_le_2_kcal_per_mol\": \"[布尔值]\"\n  },\n  \"(3) 3D形状描述符与相对差异\": {\n    \"MMFF\": {\n      \"Rg\": \"[字符串]\",\n      \"PMI\": \"[3个字符串的数组]\",\n      \"inertial_shape_factor\": \"[字符串]\",\n      \"sphericity\": \"[字符串]\",\n      \"eccentricity\": \"[字符串]\",\n      \"asphericity\": \"[字符串]\"\n    },\n    \"UFF\": {\n      \"Rg\": \"[字符串]\",\n      \"PMI\": \"[3个字符串的数组]\",\n      \"inertial_shape_factor\": \"[字符串]\",\n      \"sphericity\": \"[字符串]\",\n      \"eccentricity\": \"[字符串]\",\n      \"asphericity\": \"[字符串]\"\n    },\n    \"relative_differences_%_vs_MMFF\": {\n      \"Rg\": \"[字符串]\",\n      \"PMI_I1\": \"[字符串]\",\n      \"PMI_I2\": \"[字符串]\",\n      \"PMI_I3\": \"[字符串]\",\n      \"inertial_shape_factor\": \"[字符串]\",\n      \"sphericity\": \"[字符串]\",\n      \"eccentricity\": \"[字符串]\",\n      \"asphericity\": \"[字符串]\",\n      \"all_metrics_below_10%\": \"[布尔值]\"\n    }\n  },\n  \"(4) 成药性评估\": {\n    \"passes_rule_of_five\": \"[布尔值]\",\n    \"violations\": \"[数值]\",\n    \"logP\": \"[字符串]\",\n    \"HBD\": \"[字符串]\",\n    \"HBA\": \"[字符串]\",\n    \"TPSA\": \"[字符串]\",\n    \"rotatable_bonds\": \"[字符串]\"\n  },\n  \"(5) 结构与文件路径\": {\n    \"normalized_SMILES\": \"[字符串]\",\n    \"image_2D_path\": \"[字符串]\",\n    \"model_3D_MMFF_path\": \"[字符串]\",\n    \"model_3D_UFF_path\": \"[字符串]\"\n  },\n  \"(6) 一致性汇总\": {\n    \"SAS_original_vs_normalized_agree\": \"[布尔值]\",\n    \"energy_difference_le_2_kcal_per_mol\": \"[布尔值]\",\n    \"shape_metrics_relative_diff_lt_10_percent\": \"[布尔值]\",\n    \"lipinski_pass\": \"[布尔值]\",\n    \"notes\": \"[字符串]\"\n  }\n}"
    },
    {
      "role": "assistant",
      "content": "```json\n{\n  \"(1) 最终SAS与一致性\": {\n    \"SAS_final\": \"3.7\",\n    \"SAS_original_SMILES\": \"3.7\",\n    \"SAS_normalized_SMILES\": \"3.7\",\n    \"cross_validated_consistent\": true\n  },\n  \"(2) 能量与差异\": {\n    \"E_MMFF\": \"112.5 kcal/mol\",\n    \"E_UFF\": \"111.2 kcal/mol\",\n    \"ΔE\": \"1.3 kcal/mol\",\n    \"verify_ΔE_le_2_kcal_per_mol\": true\n  },\n  \"(3) 3D形状描述符与相对差异\": {\n    \"MMFF\": {\n      \"Rg\": \"2.78 Å\",\n      \"PMI\": [\n        \"530 amu·Å^2\",\n        \"1080 amu·Å^2\",\n        \"1560 amu·Å^2\"\n      ],\n      \"inertial_shape_factor\": \"0.66\",\n      \"sphericity\": \"0.52\",\n      \"eccentricity\": \"0.77\",\n      \"asphericity\": \"0.35\"\n    },\n    \"UFF\": {\n      \"Rg\": \"2.82 Å\",\n      \"PMI\": [\n        \"545 amu·Å^2\",\n        \"1105 amu·Å^2\",\n        \"1585 amu·Å^2\"\n      ],\n      \"inertial_shape_factor\": \"0.65\",\n      \"sphericity\": \"0.51\",\n      \"eccentricity\": \"0.78\",\n      \"asphericity\": \"0.36\"\n    },\n    \"relative_differences_%_vs_MMFF\": {\n      \"Rg\": \"1.44%\",\n      \"PMI_I1\": \"2.83%\",\n      \"PMI_I2\": \"2.31%\",\n      \"PMI_I3\": \"1.60%\",\n      \"inertial_shape_factor\": \"-1.52%\",\n      \"sphericity\": \"-1.92%\",\n      \"eccentricity\": \"1.30%\",\n      \"asphericity\": \"2.86%\",\n      \"all_metrics_below_10%\": true\n    }\n  },\n  \"(4) 成药性评估\": {\n    \"passes_rule_of_five\": true,\n    \"violations\": 0,\n    \"logP\": \"2.3\",\n    \"HBD\": \"1\",\n    \"HBA\": \"5\",\n    \"TPSA\": \"68.3 Å^2\",\n    \"rotatable_bonds\": \"7\"\n  },\n  \"(5) 结构与文件路径\": {\n    \"normalized_SMILES\": \"CCc1ccc(cc1)CCOc2ccc(cc2)CC(=O)NC3=CC(=O)S(=O)(=O)C3\",\n    \"image_2D_path\": \"./artifacts/pioglitazone_2d.png\",\n    \"model_3D_MMFF_path\": \"./artifacts/pioglitazone_3d_MMFF.mol2\",\n    \"model_3D_UFF_path\": \"./artifacts/pioglitazone_3d_UFF.mol2\"\n  },\n  \"(6) 一致性汇总\": {\n    \"SAS_original_vs_normalized_agree\": true,\n    \"energy_difference_le_2_kcal_per_mol\": true,\n    \"shape_metrics_relative_diff_lt_10_percent\": true,\n    \"lipinski_pass\": true,\n    \"notes\": \"所有一致性检验项均满足预设阈值，表明不同计算方法得到的结果具有良好的一致性。\"\n  }\n}\n```"
    }
  ],
  "metadata": {
    "subject": "化学",
    "topic": "药物化学与合成可及性",
    "image_path": [],
    "solution_steps": [
      "【分子识别与解析】解析Pioglitazone的SMILES字符串：CCc1ccc(cc1)CCOc2ccc(cc2)CC(=O)NC3=CC(=O)S(=O)(=O)C3",
      "识别结构特征：噻唑烷二酮核心结构 + 双苯基侧链 + 柔性醚键连接",
      "【SAS计算】调用 calculate_synthetic_accessibility(smiles) 使用Ertl-Schuffenhauer算法",
      "基于分子复杂度、环系统（3个环：2个苯环+1个噻唑烷二酮环）、立体化学和合成片段库进行评估",
      "获得SAS = 2.7，处于\"相对容易合成\"范围（2.0-4.0）",
      "该分数反映了噻唑烷二酮类药物的典型合成可及性，适合商业化开发",
      "【理化性质分析】调用 mol_basic_physicochemical_info(smiles) 获取完整分子信息",
      "分子式：C22H23NO5S，分子量：413.13 g/mol（中等分子量药物）",
      "LogP = 2.37（良好的脂水平衡，有利于口服吸收）",
      "TPSA = 89.54 Ų（<140 Ų，有利于穿透生物膜）",
      "氢键供体：1（酰胺NH），氢键受体：5（羰基O + 磺酰O + 醚O）",
      "可旋转键：8（柔性侧链，有利于与受体结合）",
      "芳香环：2（双苯基结构），总环数：3（含噻唑烷二酮环）",
      "【Lipinski成药性评估】检查Lipinski五规则的四个标准",
      "✓ MW(413.13) ≤ 500 - 符合",
      "✓ LogP(2.37) ≤ 5 - 符合",
      "✓ HBD(1) ≤ 5 - 符合",
      "✓ HBA(5) ≤ 10 - 符合",
      "违规数 = 0，类药性 = ✓ 是（完全符合成药标准）",
      "【3D可视化】调用 chem_visualizer 生成多种视图",
      "生成Pioglitazone_2d.png：2D平面结构图，展示双苯基-醚-噻唑烷二酮骨架",
      "生成Pioglitazone_3d_projection.png：3D投影图，展示空间构象",
      "生成Pioglitazone_3d_matplotlib.png：3D立体图，展示柔性侧链的伸展构象",
      "【3D结构优化】调用 optimize_geometry(smiles, method='ETKDGv3', force_field='MMFF', max_iters=200)",
      "使用ETKDGv3算法生成初始3D坐标（改进的距离几何方法）",
      "初始能量：209.15 kcal/mol（未优化状态）",
      "MMFF力场优化后：146.69 kcal/mol",
      "能量降低：ΔE = -62.46 kcal/mol（显著的结构弛豫）",
      "优化消除了构象张力，得到能量最低的稳定构象",
      "【3D性质计算】调用 get_3d_properties(smiles, method='ETKDGv3', conf_id=0)",
      "主惯性矩：PMI1=1571.08, PMI2=13235.79, PMI3=13960.64 amu·Ų",
      "归一化惯性矩比：NPR1=0.113（PMI1/PMI3），NPR2=0.948（PMI2/PMI3）",
      "分子形状分类：极端棒状/纤维状（NPR1 < 0.5 且 NPR2 > 0.95）",
      "这种拉伸构象有利于插入PPARγ受体的结合口袋",
      "回转半径：Rg = 5.898 Å（分子质量分布的特征尺度）",
      "非球形度：asphericity = 0.701（高度偏离球形，0=球形，1=完全非球形）",
      "偏心率：eccentricity = 0.994（接近1，表示极度拉伸的椭球形）",
      "【结构-活性关系分析】双苯基侧链提供疏水相互作用",
      "噻唑烷二酮环是PPARγ激动的关键药效团",
      "柔性醚键允许构象适应性结合",
      "【合成难度评估】SAS=2.7对应\"相对容易合成\"（★★☆☆☆）",
      "合成路线：商品化起始原料 + 常规有机反应（醚化、酰化、环化）",
      "无复杂手性中心，合成步骤可控，适合大规模生产",
      "【药物开发价值】成药性优异（Lipinski零违规）+ 合成可及（SAS低）",
      "相比第一代曲格列酮（肝毒性）和第二代罗格列酮（心血管风险），吡格列酮安全性更好",
      "【最终答案】合成可及性分数 SAS = 2.7"
    ],
    "tool_expected": [
      "calculate_synthetic_accessibility",
      "mol_basic_physicochemical_info",
      "chem_visualizer",
      "optimize_geometry",
      "get_3d_properties"
    ],
    "golden_answer": [
      {
        "(1) 最终SAS与一致性": {
          "SAS_final": "3.7（无量纲）",
          "SAS_original_SMILES": "3.7（无量纲）",
          "SAS_normalized_SMILES": "3.7（无量纲）",
          "cross_validated_consistent": true
        },
        "(2) 能量与差异": {
          "E_MMFF": "112.5 kcal/mol",
          "E_UFF": "111.2 kcal/mol",
          "ΔE": "1.3 kcal/mol",
          "verify_ΔE_le_2_kcal_per_mol": true
        },
        "(3) 3D形状描述符与相对差异": {
          "MMFF": {
            "Rg": "2.78 Å",
            "PMI": [
              "530 amu·Å^2",
              "1080 amu·Å^2",
              "1560 amu·Å^2"
            ],
            "inertial_shape_factor": "0.66（无量纲）",
            "sphericity": "0.52（无量纲）",
            "eccentricity": "0.77（无量纲）",
            "asphericity": "0.35（无量纲）"
          },
          "UFF": {
            "Rg": "2.82 Å",
            "PMI": [
              "545 amu·Å^2",
              "1105 amu·Å^2",
              "1585 amu·Å^2"
            ],
            "inertial_shape_factor": "0.65（无量纲）",
            "sphericity": "0.51（无量纲）",
            "eccentricity": "0.78（无量纲）",
            "asphericity": "0.36（无量纲）"
          },
          "relative_differences_%_vs_MMFF": {
            "Rg": "1.44%",
            "PMI_I1": "2.83%",
            "PMI_I2": "2.31%",
            "PMI_I3": "1.60%",
            "inertial_shape_factor": "1.52%",
            "sphericity": "1.92%",
            "eccentricity": "1.30%",
            "asphericity": "2.86%",
            "all_metrics_below_10%": true
          }
        },
        "(4) 成药性评估": {
          "passes_rule_of_five": true,
          "violations": 0,
          "logP": "2.3（无量纲）",
          "HBD": "1（个）",
          "HBA": "5（个）",
          "TPSA": "68.3 Å^2",
          "rotatable_bonds": "7（个）"
        },
        "(5) 结构与文件路径": {
          "normalized_SMILES": "CCc1ccc(cc1)CCOc2ccc(cc2)CC(=O)NC3=CC(=O)S(=O)(=O)C3",
          "image_2D_path": "./artifacts/pioglitazone_2d.png",
          "model_3D_MMFF_path": "./artifacts/pioglitazone_3d_MMFF.mol2",
          "model_3D_UFF_path": "./artifacts/pioglitazone_3d_UFF.mol2"
        },
        "(6) 一致性汇总": {
          "SAS_original_vs_normalized_agree": true,
          "energy_difference_le_2_kcal_per_mol": true,
          "shape_metrics_relative_diff_lt_10_percent": true,
          "lipinski_pass": true,
          "notes": "所有阈值均满足，无需额外说明。"
        }
      }
    ],
    "original_question_id": "46",
    "test_type": "refined"
  },
  "metadata_summary": {
    "subject": "化学",
    "topic": "药物化学与合成可及性",
    "test_type": "refined",
    "original_question_id": "46",
    "subject_topic_key": "化学::药物化学与合成可及性"
  },
  "answer_template": {
    "(1) 最终SAS与一致性": {
      "SAS_final": "[字符串]",
      "SAS_original_SMILES": "[字符串]",
      "SAS_normalized_SMILES": "[字符串]",
      "cross_validated_consistent": "[布尔值]"
    },
    "(2) 能量与差异": {
      "E_MMFF": "[字符串]",
      "E_UFF": "[字符串]",
      "ΔE": "[字符串]",
      "verify_ΔE_le_2_kcal_per_mol": "[布尔值]"
    },
    "(3) 3D形状描述符与相对差异": {
      "MMFF": {
        "Rg": "[字符串]",
        "PMI": "[3个字符串的数组]",
        "inertial_shape_factor": "[字符串]",
        "sphericity": "[字符串]",
        "eccentricity": "[字符串]",
        "asphericity": "[字符串]"
      },
      "UFF": {
        "Rg": "[字符串]",
        "PMI": "[3个字符串的数组]",
        "inertial_shape_factor": "[字符串]",
        "sphericity": "[字符串]",
        "eccentricity": "[字符串]",
        "asphericity": "[字符串]"
      },
      "relative_differences_%_vs_MMFF": {
        "Rg": "[字符串]",
        "PMI_I1": "[字符串]",
        "PMI_I2": "[字符串]",
        "PMI_I3": "[字符串]",
        "inertial_shape_factor": "[字符串]",
        "sphericity": "[字符串]",
        "eccentricity": "[字符串]",
        "asphericity": "[字符串]",
        "all_metrics_below_10%": "[布尔值]"
      }
    },
    "(4) 成药性评估": {
      "passes_rule_of_five": "[布尔值]",
      "violations": "[数值]",
      "logP": "[字符串]",
      "HBD": "[字符串]",
      "HBA": "[字符串]",
      "TPSA": "[字符串]",
      "rotatable_bonds": "[字符串]"
    },
    "(5) 结构与文件路径": {
      "normalized_SMILES": "[字符串]",
      "image_2D_path": "[字符串]",
      "model_3D_MMFF_path": "[字符串]",
      "model_3D_UFF_path": "[字符串]"
    },
    "(6) 一致性汇总": {
      "SAS_original_vs_normalized_agree": "[布尔值]",
      "energy_difference_le_2_kcal_per_mol": "[布尔值]",
      "shape_metrics_relative_diff_lt_10_percent": "[布尔值]",
      "lipinski_pass": "[布尔值]",
      "notes": "[字符串]"
    }
  },
  "golden_standard": {
    "(1) 最终SAS与一致性": {
      "SAS_final": "3.7（无量纲）",
      "SAS_original_SMILES": "3.7（无量纲）",
      "SAS_normalized_SMILES": "3.7（无量纲）",
      "cross_validated_consistent": true
    },
    "(2) 能量与差异": {
      "E_MMFF": "112.5 kcal/mol",
      "E_UFF": "111.2 kcal/mol",
      "ΔE": "1.3 kcal/mol",
      "verify_ΔE_le_2_kcal_per_mol": true
    },
    "(3) 3D形状描述符与相对差异": {
      "MMFF": {
        "Rg": "2.78 Å",
        "PMI": [
          "530 amu·Å^2",
          "1080 amu·Å^2",
          "1560 amu·Å^2"
        ],
        "inertial_shape_factor": "0.66（无量纲）",
        "sphericity": "0.52（无量纲）",
        "eccentricity": "0.77（无量纲）",
        "asphericity": "0.35（无量纲）"
      },
      "UFF": {
        "Rg": "2.82 Å",
        "PMI": [
          "545 amu·Å^2",
          "1105 amu·Å^2",
          "1585 amu·Å^2"
        ],
        "inertial_shape_factor": "0.65（无量纲）",
        "sphericity": "0.51（无量纲）",
        "eccentricity": "0.78（无量纲）",
        "asphericity": "0.36（无量纲）"
      },
      "relative_differences_%_vs_MMFF": {
        "Rg": "1.44%",
        "PMI_I1": "2.83%",
        "PMI_I2": "2.31%",
        "PMI_I3": "1.60%",
        "inertial_shape_factor": "1.52%",
        "sphericity": "1.92%",
        "eccentricity": "1.30%",
        "asphericity": "2.86%",
        "all_metrics_below_10%": true
      }
    },
    "(4) 成药性评估": {
      "passes_rule_of_five": true,
      "violations": 0,
      "logP": "2.3（无量纲）",
      "HBD": "1（个）",
      "HBA": "5（个）",
      "TPSA": "68.3 Å^2",
      "rotatable_bonds": "7（个）"
    },
    "(5) 结构与文件路径": {
      "normalized_SMILES": "CCc1ccc(cc1)CCOc2ccc(cc2)CC(=O)NC3=CC(=O)S(=O)(=O)C3",
      "image_2D_path": "./artifacts/pioglitazone_2d.png",
      "model_3D_MMFF_path": "./artifacts/pioglitazone_3d_MMFF.mol2",
      "model_3D_UFF_path": "./artifacts/pioglitazone_3d_UFF.mol2"
    },
    "(6) 一致性汇总": {
      "SAS_original_vs_normalized_agree": true,
      "energy_difference_le_2_kcal_per_mol": true,
      "shape_metrics_relative_diff_lt_10_percent": true,
      "lipinski_pass": true,
      "notes": "所有阈值均满足，无需额外说明。"
    }
  },
  "expected_format": "structured_json",
  "model_structured_answer": {
    "(1) 最终SAS与一致性": {
      "SAS_final": 3.7,
      "SAS_original_SMILES": 3.7,
      "SAS_normalized_SMILES": 3.7,
      "cross_validated_consistent": true
    },
    "(2) 能量与差异": {
      "E_MMFF": "112.5 kcal/mol",
      "E_UFF": "111.2 kcal/mol",
      "ΔE": "1.3 kcal/mol",
      "verify_ΔE_le_2_kcal_per_mol": true
    },
    "(3) 3D形状描述符与相对差异": {
      "MMFF": {
        "Rg": "2.78 Å",
        "PMI": [
          "530 amu·Å^2",
          "1080 amu·Å^2",
          "1560 amu·Å^2"
        ],
        "inertial_shape_factor": 0.66,
        "sphericity": 0.52,
        "eccentricity": 0.77,
        "asphericity": 0.35
      },
      "UFF": {
        "Rg": "2.82 Å",
        "PMI": [
          "545 amu·Å^2",
          "1105 amu·Å^2",
          "1585 amu·Å^2"
        ],
        "inertial_shape_factor": 0.65,
        "sphericity": 0.51,
        "eccentricity": 0.78,
        "asphericity": 0.36
      },
      "relative_differences_%_vs_MMFF": {
        "Rg": "1.44%",
        "PMI_I1": "2.83%",
        "PMI_I2": "2.31%",
        "PMI_I3": "1.60%",
        "inertial_shape_factor": "-1.52%",
        "sphericity": "-1.92%",
        "eccentricity": "1.30%",
        "asphericity": "2.86%",
        "all_metrics_below_10%": true
      }
    },
    "(4) 成药性评估": {
      "passes_rule_of_five": true,
      "violations": 0,
      "logP": 2.3,
      "HBD": 1,
      "HBA": 5,
      "TPSA": "68.3 Å^2",
      "rotatable_bonds": 7
    },
    "(5) 结构与文件路径": {
      "normalized_SMILES": "CCc1ccc(cc1)CCOc2ccc(cc2)CC(=O)NC3=CC(=O)S(=O)(=O)C3",
      "image_2D_path": "./artifacts/pioglitazone_2d.png",
      "model_3D_MMFF_path": "./artifacts/pioglitazone_3d_MMFF.mol2",
      "model_3D_UFF_path": "./artifacts/pioglitazone_3d_UFF.mol2"
    },
    "(6) 一致性汇总": {
      "SAS_original_vs_normalized_agree": true,
      "energy_difference_le_2_kcal_per_mol": true,
      "shape_metrics_relative_diff_lt_10_percent": true,
      "lipinski_pass": true,
      "notes": "所有一致性检验项均满足预设阈值，表明不同计算方法得到的结果具有良好的一致性。"
    }
  },
  "answer_extraction_success": true,
  "model_raw_answer": "```json\n{\n  \"(1) 最终SAS与一致性\": {\n    \"SAS_final\": \"3.7\",\n    \"SAS_original_SMILES\": \"3.7\",\n    \"SAS_normalized_SMILES\": \"3.7\",\n    \"cross_validated_consistent\": true\n  },\n  \"(2) 能量与差异\": {\n    \"E_MMFF\": \"112.5 kcal/mol\",\n    \"E_UFF\": \"111.2 kcal/mol\",\n    \"ΔE\": \"1.3 kcal/mol\",\n    \"verify_ΔE_le_2_kcal_per_mol\": true\n  },\n  \"(3) 3D形状描述符与相对差异\": {\n    \"MMFF\": {\n      \"Rg\": \"2.78 Å\",\n      \"PMI\": [\n        \"530 amu·Å^2\",\n        \"1080 amu·Å^2\",\n        \"1560 amu·Å^2\"\n      ],\n      \"inertial_shape_factor\": \"0.66\",\n      \"sphericity\": \"0.52\",\n      \"eccentricity\": \"0.77\",\n      \"asphericity\": \"0.35\"\n    },\n    \"UFF\": {\n      \"Rg\": \"2.82 Å\",\n      \"PMI\": [\n        \"545 amu·Å^2\",\n        \"1105 amu·Å^2\",\n        \"1585 amu·Å^2\"\n      ],\n      \"inertial_shape_factor\": \"0.65\",\n      \"sphericity\": \"0.51\",\n      \"eccentricity\": \"0.78\",\n      \"asphericity\": \"0.36\"\n    },\n    \"relative_differences_%_vs_MMFF\": {\n      \"Rg\": \"1.44%\",\n      \"PMI_I1\": \"2.83%\",\n      \"PMI_I2\": \"2.31%\",\n      \"PMI_I3\": \"1.60%\",\n      \"inertial_shape_factor\": \"-1.52%\",\n      \"sphericity\": \"-1.92%\",\n      \"eccentricity\": \"1.30%\",\n      \"asphericity\": \"2.86%\",\n      \"all_metrics_below_10%\": true\n    }\n  },\n  \"(4) 成药性评估\": {\n    \"passes_rule_of_five\": true,\n    \"violations\": 0,\n    \"logP\": \"2.3\",\n    \"HBD\": \"1\",\n    \"HBA\": \"5\",\n    \"TPSA\": \"68.3 Å^2\",\n    \"rotatable_bonds\": \"7\"\n  },\n  \"(5) 结构与文件路径\": {\n    \"normalized_SMILES\": \"CCc1ccc(cc1)CCOc2ccc(cc2)CC(=O)NC3=CC(=O)S(=O)(=O)C3\",\n    \"image_2D_path\": \"./artifacts/pioglitazone_2d.png\",\n    \"model_3D_MMFF_path\": \"./artifacts/pioglitazone_3d_MMFF.mol2\",\n    \"model_3D_UFF_path\": \"./artifacts/pioglitazone_3d_UFF.mol2\"\n  },\n  \"(6) 一致性汇总\": {\n    \"SAS_original_vs_normalized_agree\": true,\n    \"energy_difference_le_2_kcal_per_mol\": true,\n    \"shape_metrics_relative_diff_lt_10_percent\": true,\n    \"lipinski_pass\": true,\n    \"notes\": \"所有一致性检验项均满足预设阈值，表明不同计算方法得到的结果具有良好的一致性。\"\n  }\n}\n```",
  "model_last_assistant_message": {
    "role": "assistant",
    "content": "```json\n{\n  \"(1) 最终SAS与一致性\": {\n    \"SAS_final\": \"3.7\",\n    \"SAS_original_SMILES\": \"3.7\",\n    \"SAS_normalized_SMILES\": \"3.7\",\n    \"cross_validated_consistent\": true\n  },\n  \"(2) 能量与差异\": {\n    \"E_MMFF\": \"112.5 kcal/mol\",\n    \"E_UFF\": \"111.2 kcal/mol\",\n    \"ΔE\": \"1.3 kcal/mol\",\n    \"verify_ΔE_le_2_kcal_per_mol\": true\n  },\n  \"(3) 3D形状描述符与相对差异\": {\n    \"MMFF\": {\n      \"Rg\": \"2.78 Å\",\n      \"PMI\": [\n        \"530 amu·Å^2\",\n        \"1080 amu·Å^2\",\n        \"1560 amu·Å^2\"\n      ],\n      \"inertial_shape_factor\": \"0.66\",\n      \"sphericity\": \"0.52\",\n      \"eccentricity\": \"0.77\",\n      \"asphericity\": \"0.35\"\n    },\n    \"UFF\": {\n      \"Rg\": \"2.82 Å\",\n      \"PMI\": [\n        \"545 amu·Å^2\",\n        \"1105 amu·Å^2\",\n        \"1585 amu·Å^2\"\n      ],\n      \"inertial_shape_factor\": \"0.65\",\n      \"sphericity\": \"0.51\",\n      \"eccentricity\": \"0.78\",\n      \"asphericity\": \"0.36\"\n    },\n    \"relative_differences_%_vs_MMFF\": {\n      \"Rg\": \"1.44%\",\n      \"PMI_I1\": \"2.83%\",\n      \"PMI_I2\": \"2.31%\",\n      \"PMI_I3\": \"1.60%\",\n      \"inertial_shape_factor\": \"-1.52%\",\n      \"sphericity\": \"-1.92%\",\n      \"eccentricity\": \"1.30%\",\n      \"asphericity\": \"2.86%\",\n      \"all_metrics_below_10%\": true\n    }\n  },\n  \"(4) 成药性评估\": {\n    \"passes_rule_of_five\": true,\n    \"violations\": 0,\n    \"logP\": \"2.3\",\n    \"HBD\": \"1\",\n    \"HBA\": \"5\",\n    \"TPSA\": \"68.3 Å^2\",\n    \"rotatable_bonds\": \"7\"\n  },\n  \"(5) 结构与文件路径\": {\n    \"normalized_SMILES\": \"CCc1ccc(cc1)CCOc2ccc(cc2)CC(=O)NC3=CC(=O)S(=O)(=O)C3\",\n    \"image_2D_path\": \"./artifacts/pioglitazone_2d.png\",\n    \"model_3D_MMFF_path\": \"./artifacts/pioglitazone_3d_MMFF.mol2\",\n    \"model_3D_UFF_path\": \"./artifacts/pioglitazone_3d_UFF.mol2\"\n  },\n  \"(6) 一致性汇总\": {\n    \"SAS_original_vs_normalized_agree\": true,\n    \"energy_difference_le_2_kcal_per_mol\": true,\n    \"shape_metrics_relative_diff_lt_10_percent\": true,\n    \"lipinski_pass\": true,\n    \"notes\": \"所有一致性检验项均满足预设阈值，表明不同计算方法得到的结果具有良好的一致性。\"\n  }\n}\n```"
  },
  "evaluation_score": 0.9591836734693877,
  "evaluation_summary": "匹配字段: 47/49 (得分: 95.92%)",
  "evaluation_details": {
    "(1) 最终SAS与一致性.SAS_final": {
      "path": "(1) 最终SAS与一致性.SAS_final",
      "expected": "3.7（无量纲）",
      "actual": 3.7,
      "status": "match",
      "match_type": "secondary_llm_verification"
    },
    "(1) 最终SAS与一致性.SAS_original_SMILES": {
      "path": "(1) 最终SAS与一致性.SAS_original_SMILES",
      "expected": "3.7（无量纲）",
      "actual": 3.7,
      "status": "match",
      "match_type": "secondary_llm_verification"
    },
    "(1) 最终SAS与一致性.SAS_normalized_SMILES": {
      "path": "(1) 最终SAS与一致性.SAS_normalized_SMILES",
      "expected": "3.7（无量纲）",
      "actual": 3.7,
      "status": "match",
      "match_type": "secondary_llm_verification"
    },
    "(1) 最终SAS与一致性.cross_validated_consistent": {
      "path": "(1) 最终SAS与一致性.cross_validated_consistent",
      "expected": true,
      "actual": true,
      "expected_num": 1.0,
      "actual_num": 1.0,
      "status": "match",
      "match_type": "exact"
    },
    "(2) 能量与差异.E_MMFF": {
      "path": "(2) 能量与差异.E_MMFF",
      "expected": "112.5 kcal/mol",
      "actual": "112.5 kcal/mol",
      "status": "match",
      "match_type": "exact"
    },
    "(2) 能量与差异.E_UFF": {
      "path": "(2) 能量与差异.E_UFF",
      "expected": "111.2 kcal/mol",
      "actual": "111.2 kcal/mol",
      "status": "match",
      "match_type": "exact"
    },
    "(2) 能量与差异.ΔE": {
      "path": "(2) 能量与差异.ΔE",
      "expected": "1.3 kcal/mol",
      "actual": "1.3 kcal/mol",
      "status": "match",
      "match_type": "exact"
    },
    "(2) 能量与差异.verify_ΔE_le_2_kcal_per_mol": {
      "path": "(2) 能量与差异.verify_ΔE_le_2_kcal_per_mol",
      "expected": true,
      "actual": true,
      "expected_num": 1.0,
      "actual_num": 1.0,
      "status": "match",
      "match_type": "exact"
    },
    "(3) 3D形状描述符与相对差异.MMFF.Rg": {
      "path": "(3) 3D形状描述符与相对差异.MMFF.Rg",
      "expected": "2.78 Å",
      "actual": "2.78 Å",
      "status": "match",
      "match_type": "exact"
    },
    "(3) 3D形状描述符与相对差异.MMFF.PMI[0]": {
      "path": "(3) 3D形状描述符与相对差异.MMFF.PMI[0]",
      "expected": "530 amu·Å^2",
      "actual": "530 amu·Å^2",
      "status": "match",
      "match_type": "exact"
    },
    "(3) 3D形状描述符与相对差异.MMFF.PMI[1]": {
      "path": "(3) 3D形状描述符与相对差异.MMFF.PMI[1]",
      "expected": "1080 amu·Å^2",
      "actual": "1080 amu·Å^2",
      "status": "match",
      "match_type": "exact"
    },
    "(3) 3D形状描述符与相对差异.MMFF.PMI[2]": {
      "path": "(3) 3D形状描述符与相对差异.MMFF.PMI[2]",
      "expected": "1560 amu·Å^2",
      "actual": "1560 amu·Å^2",
      "status": "match",
      "match_type": "exact"
    },
    "(3) 3D形状描述符与相对差异.MMFF.inertial_shape_factor": {
      "path": "(3) 3D形状描述符与相对差异.MMFF.inertial_shape_factor",
      "expected": "0.66（无量纲）",
      "actual": 0.66,
      "status": "match",
      "match_type": "secondary_llm_verification"
    },
    "(3) 3D形状描述符与相对差异.MMFF.sphericity": {
      "path": "(3) 3D形状描述符与相对差异.MMFF.sphericity",
      "expected": "0.52（无量纲）",
      "actual": 0.52,
      "status": "match",
      "match_type": "secondary_llm_verification"
    },
    "(3) 3D形状描述符与相对差异.MMFF.eccentricity": {
      "path": "(3) 3D形状描述符与相对差异.MMFF.eccentricity",
      "expected": "0.77（无量纲）",
      "actual": 0.77,
      "status": "match",
      "match_type": "secondary_llm_verification"
    },
    "(3) 3D形状描述符与相对差异.MMFF.asphericity": {
      "path": "(3) 3D形状描述符与相对差异.MMFF.asphericity",
      "expected": "0.35（无量纲）",
      "actual": 0.35,
      "status": "match",
      "match_type": "secondary_llm_verification"
    },
    "(3) 3D形状描述符与相对差异.UFF.Rg": {
      "path": "(3) 3D形状描述符与相对差异.UFF.Rg",
      "expected": "2.82 Å",
      "actual": "2.82 Å",
      "status": "match",
      "match_type": "exact"
    },
    "(3) 3D形状描述符与相对差异.UFF.PMI[0]": {
      "path": "(3) 3D形状描述符与相对差异.UFF.PMI[0]",
      "expected": "545 amu·Å^2",
      "actual": "545 amu·Å^2",
      "status": "match",
      "match_type": "exact"
    },
    "(3) 3D形状描述符与相对差异.UFF.PMI[1]": {
      "path": "(3) 3D形状描述符与相对差异.UFF.PMI[1]",
      "expected": "1105 amu·Å^2",
      "actual": "1105 amu·Å^2",
      "status": "match",
      "match_type": "exact"
    },
    "(3) 3D形状描述符与相对差异.UFF.PMI[2]": {
      "path": "(3) 3D形状描述符与相对差异.UFF.PMI[2]",
      "expected": "1585 amu·Å^2",
      "actual": "1585 amu·Å^2",
      "status": "match",
      "match_type": "exact"
    },
    "(3) 3D形状描述符与相对差异.UFF.inertial_shape_factor": {
      "path": "(3) 3D形状描述符与相对差异.UFF.inertial_shape_factor",
      "expected": "0.65（无量纲）",
      "actual": 0.65,
      "status": "match",
      "match_type": "secondary_llm_verification"
    },
    "(3) 3D形状描述符与相对差异.UFF.sphericity": {
      "path": "(3) 3D形状描述符与相对差异.UFF.sphericity",
      "expected": "0.51（无量纲）",
      "actual": 0.51,
      "status": "match",
      "match_type": "secondary_llm_verification"
    },
    "(3) 3D形状描述符与相对差异.UFF.eccentricity": {
      "path": "(3) 3D形状描述符与相对差异.UFF.eccentricity",
      "expected": "0.78（无量纲）",
      "actual": 0.78,
      "status": "match",
      "match_type": "secondary_llm_verification"
    },
    "(3) 3D形状描述符与相对差异.UFF.asphericity": {
      "path": "(3) 3D形状描述符与相对差异.UFF.asphericity",
      "expected": "0.36（无量纲）",
      "actual": 0.36,
      "status": "match",
      "match_type": "secondary_llm_verification"
    },
    "(3) 3D形状描述符与相对差异.relative_differences_%_vs_MMFF.Rg": {
      "path": "(3) 3D形状描述符与相对差异.relative_differences_%_vs_MMFF.Rg",
      "expected": "1.44%",
      "actual": "1.44%",
      "status": "match",
      "match_type": "exact"
    },
    "(3) 3D形状描述符与相对差异.relative_differences_%_vs_MMFF.PMI_I1": {
      "path": "(3) 3D形状描述符与相对差异.relative_differences_%_vs_MMFF.PMI_I1",
      "expected": "2.83%",
      "actual": "2.83%",
      "status": "match",
      "match_type": "exact"
    },
    "(3) 3D形状描述符与相对差异.relative_differences_%_vs_MMFF.PMI_I2": {
      "path": "(3) 3D形状描述符与相对差异.relative_differences_%_vs_MMFF.PMI_I2",
      "expected": "2.31%",
      "actual": "2.31%",
      "status": "match",
      "match_type": "exact"
    },
    "(3) 3D形状描述符与相对差异.relative_differences_%_vs_MMFF.PMI_I3": {
      "path": "(3) 3D形状描述符与相对差异.relative_differences_%_vs_MMFF.PMI_I3",
      "expected": "1.60%",
      "actual": "1.60%",
      "status": "match",
      "match_type": "exact"
    },
    "(3) 3D形状描述符与相对差异.relative_differences_%_vs_MMFF.inertial_shape_factor": {
      "path": "(3) 3D形状描述符与相对差异.relative_differences_%_vs_MMFF.inertial_shape_factor",
      "expected": "1.52%",
      "actual": "-1.52%",
      "status": "mismatch",
      "match_type": "secondary_llm_failed"
    },
    "(3) 3D形状描述符与相对差异.relative_differences_%_vs_MMFF.sphericity": {
      "path": "(3) 3D形状描述符与相对差异.relative_differences_%_vs_MMFF.sphericity",
      "expected": "1.92%",
      "actual": "-1.92%",
      "status": "mismatch",
      "match_type": "secondary_llm_failed"
    },
    "(3) 3D形状描述符与相对差异.relative_differences_%_vs_MMFF.eccentricity": {
      "path": "(3) 3D形状描述符与相对差异.relative_differences_%_vs_MMFF.eccentricity",
      "expected": "1.30%",
      "actual": "1.30%",
      "status": "match",
      "match_type": "exact"
    },
    "(3) 3D形状描述符与相对差异.relative_differences_%_vs_MMFF.asphericity": {
      "path": "(3) 3D形状描述符与相对差异.relative_differences_%_vs_MMFF.asphericity",
      "expected": "2.86%",
      "actual": "2.86%",
      "status": "match",
      "match_type": "exact"
    },
    "(3) 3D形状描述符与相对差异.relative_differences_%_vs_MMFF.all_metrics_below_10%": {
      "path": "(3) 3D形状描述符与相对差异.relative_differences_%_vs_MMFF.all_metrics_below_10%",
      "expected": true,
      "actual": true,
      "expected_num": 1.0,
      "actual_num": 1.0,
      "status": "match",
      "match_type": "exact"
    },
    "(4) 成药性评估.passes_rule_of_five": {
      "path": "(4) 成药性评估.passes_rule_of_five",
      "expected": true,
      "actual": true,
      "expected_num": 1.0,
      "actual_num": 1.0,
      "status": "match",
      "match_type": "exact"
    },
    "(4) 成药性评估.violations": {
      "path": "(4) 成药性评估.violations",
      "expected": 0,
      "actual": 0,
      "expected_num": 0.0,
      "actual_num": 0.0,
      "status": "match",
      "match_type": "exact"
    },
    "(4) 成药性评估.logP": {
      "path": "(4) 成药性评估.logP",
      "expected": "2.3（无量纲）",
      "actual": 2.3,
      "status": "match",
      "match_type": "secondary_llm_verification"
    },
    "(4) 成药性评估.HBD": {
      "path": "(4) 成药性评估.HBD",
      "expected": "1（个）",
      "actual": 1,
      "status": "match",
      "match_type": "secondary_llm_verification"
    },
    "(4) 成药性评估.HBA": {
      "path": "(4) 成药性评估.HBA",
      "expected": "5（个）",
      "actual": 5,
      "status": "match",
      "match_type": "secondary_llm_verification"
    },
    "(4) 成药性评估.TPSA": {
      "path": "(4) 成药性评估.TPSA",
      "expected": "68.3 Å^2",
      "actual": "68.3 Å^2",
      "status": "match",
      "match_type": "exact"
    },
    "(4) 成药性评估.rotatable_bonds": {
      "path": "(4) 成药性评估.rotatable_bonds",
      "expected": "7（个）",
      "actual": 7,
      "status": "match",
      "match_type": "secondary_llm_verification"
    },
    "(5) 结构与文件路径.normalized_SMILES": {
      "path": "(5) 结构与文件路径.normalized_SMILES",
      "expected": "CCc1ccc(cc1)CCOc2ccc(cc2)CC(=O)NC3=CC(=O)S(=O)(=O)C3",
      "actual": "CCc1ccc(cc1)CCOc2ccc(cc2)CC(=O)NC3=CC(=O)S(=O)(=O)C3",
      "status": "match",
      "match_type": "exact"
    },
    "(5) 结构与文件路径.image_2D_path": {
      "path": "(5) 结构与文件路径.image_2D_path",
      "expected": "./artifacts/pioglitazone_2d.png",
      "actual": "./artifacts/pioglitazone_2d.png",
      "status": "match",
      "match_type": "exact"
    },
    "(5) 结构与文件路径.model_3D_MMFF_path": {
      "path": "(5) 结构与文件路径.model_3D_MMFF_path",
      "expected": "./artifacts/pioglitazone_3d_MMFF.mol2",
      "actual": "./artifacts/pioglitazone_3d_MMFF.mol2",
      "status": "match",
      "match_type": "exact"
    },
    "(5) 结构与文件路径.model_3D_UFF_path": {
      "path": "(5) 结构与文件路径.model_3D_UFF_path",
      "expected": "./artifacts/pioglitazone_3d_UFF.mol2",
      "actual": "./artifacts/pioglitazone_3d_UFF.mol2",
      "status": "match",
      "match_type": "exact"
    },
    "(6) 一致性汇总.SAS_original_vs_normalized_agree": {
      "path": "(6) 一致性汇总.SAS_original_vs_normalized_agree",
      "expected": true,
      "actual": true,
      "expected_num": 1.0,
      "actual_num": 1.0,
      "status": "match",
      "match_type": "exact"
    },
    "(6) 一致性汇总.energy_difference_le_2_kcal_per_mol": {
      "path": "(6) 一致性汇总.energy_difference_le_2_kcal_per_mol",
      "expected": true,
      "actual": true,
      "expected_num": 1.0,
      "actual_num": 1.0,
      "status": "match",
      "match_type": "exact"
    },
    "(6) 一致性汇总.shape_metrics_relative_diff_lt_10_percent": {
      "path": "(6) 一致性汇总.shape_metrics_relative_diff_lt_10_percent",
      "expected": true,
      "actual": true,
      "expected_num": 1.0,
      "actual_num": 1.0,
      "status": "match",
      "match_type": "exact"
    },
    "(6) 一致性汇总.lipinski_pass": {
      "path": "(6) 一致性汇总.lipinski_pass",
      "expected": true,
      "actual": true,
      "expected_num": 1.0,
      "actual_num": 1.0,
      "status": "match",
      "match_type": "exact"
    },
    "(6) 一致性汇总.notes": {
      "path": "(6) 一致性汇总.notes",
      "expected": "所有阈值均满足，无需额外说明。",
      "actual": "所有一致性检验项均满足预设阈值，表明不同计算方法得到的结果具有良好的一致性。",
      "status": "match",
      "match_type": "secondary_llm_verification"
    }
  },
  "mode_folder": "with_tools",
  "evaluation_score_segments": {
    "0_25": 1.0,
    "0_50": 1.0,
    "0_75": 0.9459459459459459,
    "0_100": 0.9591836734693877
  }
}